Skip to content
COVID lockdowns caused a much shorter flu season than usual, but we’re already seeing record numbers of influenza in Australia and elsewhere in the […]
As influenza cases rise in Australia, Seqirus prepares for US flu season Read More »
It feels like just yesterday that Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), visited member company Novavax with Maryland
John Trizzino, Executive Vice President, Chief Commercial Officer, and Chief Business Officer of Novavax, joined Good Day BIO Live at the BIO International Convention,
Vaccine in 100 days ‘extraordinarily possible,’ says John Trizzino of Novavax Read More »
The two-dose Novavax COVID vaccine became the fourth coronavirus vaccine available in the United States after the Food and Drug Administration (FDA) authorized its
FDA authorizes Novavax COVID vaccine for emergency use Read More »
In spite of an increase in pet adoptions, a recent analysis by Elanco reveals many animals lack adequate protection against common illnesses including leptospirosis
Many pets lack protection against preventable diseases, Elanco survey reveals Read More »
During the COVID-19 pandemic, drug-resistant infections and resultant fatalities increased in hospitals by 15%, erasing years of progress in the United States in the
CDC reports increase in drug-resistant infections during pandemic Read More »
Prompted by the silent pandemic of antimicrobial resistance (AMR), which has raised a significant public health concern with 1.27 million deaths per year directly
WHO: New and improved vaccines urgently needed to tackle AMR Read More »
The U.S. government has secured 3.2 million doses of Novavax’ COVID-19 vaccine (NVX-CoV2373), Novavax Inc. announced on Monday. The Department of Health and Human
U.S. orders 3.2 million doses of Novavax COVID vaccine Read More »
Just a couple of weeks after the U.S. Food and Drug Administration (FDA) suggested that COVID-19 vaccine manufacturers modify their boosters to target the
Moderna’s Omicron booster produces stronger reaction to subvariants, company says Read More »
Last week, the U.S. Food and Drug Administration (FDA) approved Pfizer and BioNTech’s supplemental Biologics License Application (sBLA) for their COVID-19 vaccine, Comirnaty, for
FDA gives full approval to Pfizer-BioNTech COVID vaccine for teenagers Read More »
